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Abstract
Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare low-grade 
malignant-potential epithelial tumor that predominantly affects young 
women aged 20–35 years with a mean age of 22 years. It is currently cat-
egorized in the World Health Organization classification under exocrine 
pancreatic tumor. Here, we present two cases of SPN with initial presenta-
tion of large intra-abdominal masses. Both patients underwent successful 
en bloc distal pancreatectomy and splenectomy. Local recurrence and 
distant metastasis were not detected at the follow up at 21 months and 9 
years respectively. In summary, a large, well-encapsulated cystic mass in 
the pancreas of a young woman should raise suspicion of SPN. [Tzu Chi 
Med J 2009;21(1):81–84]
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1. Introduction
Solid pseudopapillary neoplasm (SPN) is an uncom-
mon pancreatic neoplasm and accounts for only 5% of 
cystic pancreatic tumors and about 1–2% of exocrine 
pancreatic cancers [1,2]. SPN is a low-grade malignant-
potential epithelial tumor, and predominantly affects 
young women aged 20–35 years [2]. In contrast to the 
almost invariable lethal behavior of pancreatic ductal 
adenocarcinomas, most SPNs, although often large in 
size, are usually well circumscribed, and complete sur-
gical resection has been reported to cure more than 
95% of patients with SPN limited to the pancreas [1]. 
Frantz first described this tumor in 1959 [3]. To date, 
more than 700 well-documented cases of pancreatic 
SPNs have been reported in the English literature [2]. 
Previously, this tumor was reported using different 
terms such as: papillary epithelial neoplasm [4], papil-
lary cystic neoplasm [5], solid and papillary epithelial 
neoplasm [6], solid and cystic acinar tumor [7], papil-
lary and solid neoplasm [8], papillary cystic epithelial 
neoplasm [9], papillary cystic carcinoma [10], solid and 
cystic papillary tumor [11], and Frantz’s tumor [12], 
depending on the proportion of their various compo-
nents. However, these terms do not exactly reflect what 
is observed either grossly or microscopically. Since 
being reclassified by World Health Organization in 
1996, solid pseudopapillary neoplasm of the pancreas 
has been recognized as the internationally accepted 
nomenclature [13].
We present our experience of the surgical man-
agement of solid pseudopapillary neoplasms of the 
pancreas in two women who initial presented with 
large intra-abdominal masses.
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2. Case reports
2.1. Case 1
A previously healthy woman aged 43 years was admit-
ted to our institute because of intermittent vague epi-
gastric pain for 1 month. She had postprandial vomiting 
and reported recent progressive increases in abdom-
inal girth. On physical examination, one ill-defined, 
firm, non-tender mass was palpable in the left upper 
quadrant of her abdomen. Laboratory examinations 
demonstrated normal levels of pancreatic enzymes 
and normal liver function test results. The serum 
tumor markers such as alpha-fetoprotein, carcinoem-
bryonic antigen, carbohydrate antigen 19-9 (CA19-9) 
and carbohydrate antigen 15-3 (CA15-3) were within 
reference ranges and her cancer antigen 125 level was 
74.5 IU/mL. On a contrast-enhanced abdominal com-
puted tomography (CT) scan, one 11-cm heterogene-
ous, lobulated retroperitoneal mass was identified 
near the pancreatic tail (Fig. 1). The tumor displaced 
the stomach anteriorly and was adherent to splenic 
flexure of the colon.
The patient underwent elective laparotomy and a 
large tumor measuring 15 × 12 cm in size with a smooth 
grayish white capsule was identified in the pancreatic 
tail. En bloc distal pancreatectomy and splenectomy 
were performed with a gross negative resection mar-
gin. During the operation, there was no evidence of 
distant metastasis to the liver, regional lymph nodes 
or the peritoneal cavity. The postoperative recovery 
went well and the patient was discharged on postop-
erative day 7. Neither local recurrence nor distant me-
tastasis were detected from abdominal CT scans 
during a 21-month follow-up period.
Grossly, the grayish white pancreatic tumor was 
15 × 14 × 10 cm in size. On cross section, the tumor 
showed focal hemorrhage and central necrosis (Fig. 2). 
Microscopically, the pancreatic tumor showed marked 
cellular proliferation in the solid areas that alternated 
with a pseudopapillary and cystic pattern (Fig. 3). 
Immunochemical stains disclosed that the neoplas-
tic cells were reactive for CD10, vimentin, neuron-
specific enolase (NSE), synaptophysin and progesterone 
receptor.
2.2. Case 2
A woman aged 43 years presented with postprandial 
abdominal fullness for 1 week. On physical examina-
tion, one ill-defined palpable mass was found in the 
left upper quadrant of her abdomen. All hematologi-
cal, biochemical parameters and tumor markers were 
within references ranges.
Fig. 1 — Abdominal computed tomography shows one 
heterogeneous, multiloculated and well-encapsulated 
huge mass near the pancreatic tail.
Fig. 2 — The pancreatic tail tumor is well circumscribed 
and shows focal hemorrhage on cross section.
Fig. 3 — The tumor shows proliferation in solid areas that 
alternates between a pseudopapillary (arrow) and cystic 
pattern (hematoxylin & eosin, 40´).
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Abdominal ultrasonography demonstrated one 
8 × 6 cm multiloculated cystic mass with internal homo-
geneous echogenicity and septation formation in the 
left upper quadrant of her abdomen. Contrast-enhanced 
CT confirmed an 11 × 9 cm heterogeneous space oc-
cupying the mass, which contained cystic and solid 
components, in the tail of the pancreas. After contrast 
injection, the solid part of the tumor showed moderate 
to strong enhancement.
She underwent elective laparotomy and one 9-cm 
well-circumscribed mass was identified in the tail of 
the pancreas. En bloc resection of the tumor in addi-
tion to distal pancreatectomy and splenectomy was 
performed. No regional lymphadenopathy was found 
during the operation. The postoperative recovery was 
unremarkable and the patient was discharged on post-
operative day 12. During a 9-year follow-up period, 
physical examination, abdominal CT and ultrasound 
did not reveal local recurrence or distant metastasis.
On gross examination, the pancreatic tumor was 
oval, 9 × 6 × 5 cm in size, and was surrounded by a 
grayish-white smooth fibrous capsule. On cross sec-
tion, the tumor showed mainly cystic and partially solid 
components. Microscopically, the neoplastic cells ex-
hibited histological architecture and features typical 
of a solid pseudopapillary neoplasm.
3. Discussion
The precise incidence of pancreatic SPN in the Chinese 
population is not known because of its rarity. Lam et al 
reported eight SPNs during a 24-year period and this 
accounted for 2.5% of primary pancreatic tumors in 
Hong Kong Chinese [14]. There is a female preponder-
ance of SPN with a female-to-male ratio of 9.78:1 [2], 
although rare cases have been reported in children 
and men [14]. The age at diagnosis ranged from 2 to 
85 years with a mean age of 21.9 years [2]. Both of 
our cases were women and both were aged 43 years 
old at diagnosis.
The initial presentations of SPN are usually non-
specific. Upper abdominal pain is the most common 
symptom (46.5%), followed by a slowly enlarged, pal-
pable, non-tender upper abdominal mass (34.8%). 
Asymptomatic cases are reported in 15.5% of cases 
[2], and the lesions are detected either after routine 
examination or after blunt abdominal injury. Because 
of these subtle symptoms, the tumor size can be 
quite large (mean diameter of 6.08 cm) at diagnosis 
with 83% of cases more than 5 cm in diameter [2]. 
The most common location of the SPN is the tail 
(35.9%) and the head (34%) of the pancreas [2]. Both 
of our cases had tumors larger than 5 cm located in 
the pancreatic tail. Thus a large cystic mass in the 
pancreas of a young woman should raise suspicion 
for SPN.
Accurate preoperative diagnosis of SPN is difficult 
because of the similarity of the findings among cystic 
lesions of the pancreas. The differential diagnosis in-
cludes disoncogenetic cysts, retention cysts, pseudo-
cysts, hydatid cysts and any cystic or solid pancreatic 
lesions such as serous cystadenoma or cystadenocar-
cinoma, microcystic adenoma, lymphangioma, heman-
gioma, mucinous cystic neoplasms, cystic islet cell 
tumors, and acinar cell cystadenocarcinoma [2,14]. 
Imaging studies of SPNs that help with differentiation 
include abdominal ultrasound, endoscopic ultrasound, 
abdominal CT and magnetic resonance imaging (MRI) 
and, in some reports, fine needle aspiration biopsy 
(FNAB) or cytology. Characteristic abdominal ultrasound 
and CT demonstrate a large, round, well-encapsulated, 
heterogeneous mass with solid and cystic components 
and displacement of adjacent viscera. Although some 
image characteristics are suggestive of SPN, percuta-
neous fine needle cytology of the cystic wall can be 
used to obtain a possible preoperative histological di-
agnosis [15]. However, some authors have suggested 
that FNAB should be avoided because of the potential 
risk of tumor spillage, which may compromise surgi-
cal cure [16,17]. In our experience, FNAB is not nec-
essary if the tumor is resectable according to the 
preoperative image evaluation.
SPN exhibits pathological features and is diagnos-
able based on the classic histological appearance of 
the neoplasm. Grossly, SPN commonly has a fibrous 
pseudocapsule surrounding the tumor, and is usually 
demarcated from the pancreas. There are variable 
combinations of solid hemorrhagic and cystic necrosis 
areas [1]. Microscopically, the neoplastic cell is quite 
uniform with a combination of solid, pseudopapillary 
or hemorrhagic pseudocystic structures in various pro-
portions. Histological indicators predicting the aggres-
sive behavior of SPNs include capsule thickness of 
more than 2 mm, high nuclear grade, prominent necro-
biotic nests, capsule invasion into the surrounding 
normal pancreatic tissue and vascular invasion [1].
In contrast to conventional ductal adenocarcino-
mas, complete surgical resection of SPNs has been 
reported to provide a more than 95% cure rate [1]. 
Thus the majority of SPNs are considered to be of low 
malignant potential with only 10–15% of cases being 
malignant, showing local infiltration, recurrence or dis-
tant metastasis [18]. Complete surgical removal with 
en bloc resection of the involved organ is the treat-
ment of choice. Distal pancreatectomy with or with-
out splenic preservation can be performed for tumors 
in the body or tail of the pancreas, and a classic 
or pylorus-preserving pancreaticoduodenectomy for 
tumors of the pancreatic head [14]. Invasion to the 
portal vein or superior mesenteric vein or artery 
should not be included as a criterion for nonresecta-
bility of these pancreatic neoplasms [2]. From a surgi-
cal standpoint, because of its favorable tumor biology, 
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an aggressive approach to the occasional neoplasm 
in the proximal pancreas encasing the superior mes-
enteric vein and superior mesenteric artery may even 
be justified. Extensive lymph node dissection is not 
indicated when the disease is localized [19,20]. Long-
term survival is often the outcome, even with the pres-
ence of metastatic disease on initial presentation [2]. 
Overall, the 2-year survival rate for SPNs (with metas-
tasis or not) is 97% and the 5-year survival rate is 
about 95% [2]. In our study, Case 2 was free of dis-
ease during the 9-year follow-up period after complete 
resection of the primary tumor.
In summary, a diagnosis of SPN should be consid-
ered in young women presenting with large and well-
circumscribed pancreatic cystic masses. Despite the 
large size of SPNs and their ability for local invasion, 
their relatively low malignancy means that aggressive 
treatment with complete surgical resection of both 
the primary and metastatic lesions offers high cure 
rates.
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